🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If you're watching the #AACR22 session on Drug Resistance Challenges/Prospects - don't miss the review in Cancer Discovery by speaker Peter Sorger: Independent Drug Action in Combination Therapy: Implications for Precision Oncology Deborah Plana, MD, PhD Adam C Palmer aacrjournals.org/cancerdiscover…

“Our ultimate goal is to make precision oncology more effective and create meaningful patient benefit,” says Dr. Anil Korkut. How a new bioinformatics platform developed at MD Anderson takes us one step closer: fal.cn/3nL9O Anil Korkut #AACR22 #EndCancer

We are so proud and happy that our manuscript on combination therapies and oncogenic co-alterations is just published. Chris Sander aka cscbio, Scott Kopetz, Xubin Li, Timothy Yap; Cancer Discovery - #AACR22;

Thrilled with our paper online today: Glioma progression is shaped by genetic evolution and microenvironment interactions cell.com/cell/fulltext/… magnus opus by Fred Varn

An insightful commentary on our recent publication ( bit.ly/3xrNErk) by Benjamin Haibe-Kains and Trevor J. Pugh in Cancer Discovery –clinical implementation, reproducibility, data sharing, collaborations "although challenges remain". Elizabeth McKenna Xubin Li aacrjournals.org/cancerdiscover…

Could machine learning fuel a reproducibility crisis in science? go.nature.com/3cwfkmS

Introducing scPerturb, a collection of 44 single cell perturbation datasets with unified annotations available at scperturb.org (1/5)

ICYMI: Final version of the Cancer Discovery paper on T cell trajectories in pancreatic cancer is now online. Magnum opus from the MD Anderson Cancer Center #PancreaticCancer #Moonshot team. Single cell RNAseq & TCRseq on 80,000 T cells, treasure trove for mining targets! aacrjournals.org/cancerdiscover…

BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer dlvr.it/SYKwTZ

Combination therapy to target epigenetic (BET/BRD4) and apoptotic (MCL1) mechanisms. Breast cancer. Lipid metabolism and EGFR signaling. Adaptive responses to therapy, multi-omics, computational modeling. Augustin Luna Chris Sander aka cscbio MD Anderson Cancer Center @NCIsysbio Xubin Li @naborala

This is going to be exciting.

At last! Happy to share our paper on CellOracle – a computational method for dissecting cell identity via network inference and in silico gene perturbation, led by the amazing Kenji Kamimoto: nature.com/articles/s4158…

This was a great symposium @UtCompPnco and CPRIT on Computational Oncology. Hoping many new collaborations will rise from this meeting.

Our recent paper on statistical analysis and inference of tumor-immune interactions is out. ImogiMap web app for custom analyses. bioinformatics.mdanderson.org/apps/imogimap/, MD Anderson Cancer Center Communications Biology Augustin Luna Behnaz Bozorgui #PrecisionOncology #ImmunoOncology

Risk of pancreatic cancer predicted using machine learning. International collaboration. Brunak Lab Hale Family Center For Pancreatic Cancer Research Harvard Medical School HMS_SysBio Pete Kraft NF Bo Yuan Davide Placido Debora Marks Chris Sander aka cscbio nature.com/articles/s4159… hms.harvard.edu/news

statistical analysis and inference of tumor-immune interactions. ImogiMap web app: bioinformatics.mdanderson.org/apps/imogimap/, MD Anderson Cancer Center Communications Biology Augustin Luna Behnaz Bozorgui #PrecisionOncology #ImmunoOncology

Congratulations to the 2023 class of Andrew Sabin Family Fellows. This fellowship program provides funding to 10 early career clinicians and scientists to deliver breakthroughs to #EndCancer. bit.ly/44Vx2Ge Joseph Arthur, MD Qing Ding, MD/PHD Robert Jenq Pavan Bachireddy Anil Korkut

Today, CPRIT awarded MD Anderson 16 grants totaling over $25.5 million, which will support our cancer prevention programs, faculty recruitment and cancer research across various fields. Read more: bit.ly/3UQOXw6 Peter WT Pisters, MD #EndCancer

After a lifetime in science, I know that our colleagues have huge impacts on our lives, both scientifically and personally. Last fall I lost both a friend and one of the colleagues who had the most impact on my work and our field, Stanford's Bill Weis 1/n rupress.org/jcb/article-pd…

A spatially resolved single cell proteomic atlas of Small Bowel Adenocarcinoma. A major resource for a rare cancer; ~600K cells; spatial immune features in tumor and matched normal niches may predict survival #spatialbiology #highlymultiplexedimaging biorxiv.org/content/10.110…